These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 8207678
21. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides. Shirokova EA, Jasko MV, Khandazhinskaya AL, Ivanov AV, Yanvarev DV, Skoblov YS, Mitkevich VA, Bocharov EV, Pronyaeva TR, Fedyuk NV, Kukhanova MK, Pokrovsky AG. J Med Chem; 2004 Jul 01; 47(14):3606-14. PubMed ID: 15214788 [Abstract] [Full Text] [Related]
22. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. McGuigan C, Cahard D, Sheeka HM, De Clercq E, Balzarini J. J Med Chem; 1996 Apr 12; 39(8):1748-53. PubMed ID: 8648614 [Abstract] [Full Text] [Related]
23. cycloSal-d4TMP pronucleotides structural variations, mechanistic insights and antiviral activity. Meiera C, Renzea J, Ducho C, Balzarini J. Curr Top Med Chem; 2002 Oct 12; 2(10):1111-21. PubMed ID: 12173970 [Abstract] [Full Text] [Related]
24. Toxicokinetics of 2',3'-didehydro-3'-deoxythymidine, stavudine (D4T). Kaul S, Dandekar KA, Schilling BE, Barbhaiya RH. Drug Metab Dispos; 1999 Jan 12; 27(1):1-12. PubMed ID: 9884303 [Abstract] [Full Text] [Related]
27. Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T). Sidwell RW, Hitchcock M, Okleberry KM, Burger RA, Warren RP, Morrey JD. Antiviral Res; 1992 Oct 01; 19(4):313-24. PubMed ID: 1334395 [Abstract] [Full Text] [Related]
28. Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent. Benzaria S, Pierra C, Bardiot D, Cretton-Scott E, Bridges EG, Zhou XJ, Standring D, Gosselin G. Nucleosides Nucleotides Nucleic Acids; 2003 Oct 01; 22(5-8):1003-6. PubMed ID: 14565331 [Abstract] [Full Text] [Related]
29. In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine. Cretton EM, Zhou Z, Kidd LB, McClure HM, Kaul S, Hitchcock MJ, Sommadossi JP. Antimicrob Agents Chemother; 1993 Sep 01; 37(9):1816-25. PubMed ID: 8239589 [Abstract] [Full Text] [Related]
30. Synthesis, physicochemical and pharmacokinetic studies of potential prodrugs of beta-L-2'-deoxycytidine, a selective and specific anti-HBV agent. Pierra C, Benzaria S, Dukhan D, Loi AG, La Colla P, Bridges E, Mao J, Standring D, Sommadossi JP, Gosselin G. Antivir Chem Chemother; 2004 Sep 01; 15(5):269-79. PubMed ID: 15535049 [Abstract] [Full Text] [Related]
32. Novel 4'-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity. Dutschman GE, Grill SP, Gullen EA, Haraguchi K, Takeda S, Tanaka H, Baba M, Cheng YC. Antimicrob Agents Chemother; 2004 May 01; 48(5):1640-6. PubMed ID: 15105115 [Abstract] [Full Text] [Related]
33. Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agent. Ray AS, Yang Z, Chu CK, Anderson KS. Antimicrob Agents Chemother; 2002 Mar 01; 46(3):887-91. PubMed ID: 11850281 [Abstract] [Full Text] [Related]
39. Dipeptidyl peptidase IV dependent water-soluble prodrugs of highly lipophilic bicyclic nucleoside analogues. Diez-Torrubia A, Balzarini J, Andrei G, Snoeck R, De Meester I, Camarasa MJ, Velázquez S. J Med Chem; 2011 Mar 24; 54(6):1927-42. PubMed ID: 21332170 [Abstract] [Full Text] [Related]
40. Oral absorption of anti-acquired immune deficiency syndrome nucleoside analogues. 2. Carrier-mediated intestinal transport of stavudine in rat and rabbit preparations. Waclawski AP, Sinko PJ. J Pharm Sci; 1996 May 24; 85(5):478-85. PubMed ID: 8742938 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]